Hospital Universitario de Cruces-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2022

  1. Intralymphatic GAD-Alum (Diamyd®) Improves Glycemic Control in Type 1 Diabetes With HLA DR3-DQ2

    Journal of Clinical Endocrinology and Metabolism, Vol. 107, Núm. 9, pp. 2644-2651

2017

  1. Recommendations for the diagnosis and treatment of classic forms of 21-hydroxylase-deficient congenital adrenal hyperplasia

    Anales de Pediatria, Vol. 87, Núm. 2, pp. 116.e1-116.e10